𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Promoter methylation of the RGC32 gene in nonsmall cell lung cancer

✍ Scribed by Dong Sun Kim; Ji Yun Lee; Su Man Lee; Jin Eun Choi; Sukki Cho; Jae Yong Park


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
249 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Multiple gene methylation of nonsmall ce
✍ Yan Wang; Dingdong Zhang; Wenli Zheng; Junfeng Luo; Yunfei Bai; Zuhong Lu πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 393 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Aberrant DNA methylation of the CpG islands for cancer‐related genes is among the earliest and most frequent alterations in cancer and may be useful for diagnosing cancer or evaluating recurrent disease. ## METHODS In this study, a 3‐dimensional (3‐D), polyacrylamide ge

Implications of key trials in advanced n
✍ Philip D. Bonomi πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 163 KB

## Abstract Many different targeted therapies with varying mechanisms of action have been added to standard first‐line chemotherapy doublets in an effort to improve survival of patients with advanced nonsmall cell lung cancer (NSCLC). Only 2 targeted therapiesβ€”bevacizumab and cetuximabβ€”have been as

Aberrant methylation of E-cadherin and H
✍ Dong Sun Kim; Mi Jin Kim; Ji Yun Lee; Young Zoo Kim; Eun Jin Kim; Jae Yong Park πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 233 KB

## Abstract ## BACKGROUND. Lung cancer is the leading cause of cancer deaths worldwide. The epigenetic inactivation of certain genes by aberrant promoter methylation plays an important role in the pathogenesis of lung cancer. In addition, DNA hypermethylation is an extremely promising cancer marke